NOTICE OF UPGRADE

Our websites will be unavailable between the hours of AEST 4AM September 17, 2022 and AEST 11PM on date September 18, 2022

InvestoGain Australia
 

SEARCH LISTED COMPANY


Any AUS or NZ company

Browse Australian listed companies

0-9A B C D E F G H I J K L M N O P Q R S T U V W XY Z

Browse current Australian managed funds

0-9A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

SEARCH PRIVATE COMPANY


SEARCH FUNDS

Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:

THE HYDRATION PHARMACEUTICALS COMPANY LIMITED (HPC)

Click here for free access to this company's:
ASX, Legal & CGT Status

Former (or subsequent) names

 

Shareholder links

Our website ranking of HPC: rating 2
(2 out of 5)
COMPANY WEBSITE:

 

REGISTRY:

Automic Group
Level 5, 191 ST GEORGES TERRACE PERTH WA 6000
Tel : +61 (2) 8072 1400 or 1300 288 664 (within Australia)
RegistryWebsite RegistryEmail

Company details

ISIN: AU0000187957
Address: C/- CDPlus Corporate Services Pty Ltd, 'Rialto South Tower', Level 42, 525 Collins Street, MELBOURNE, VIC, AUSTRALIA, 3000
Tel:  +61 3 9614 2444

Date first listed: 29/12/2021

Activities: The marketing and sale of liquid, tablet and powder hydration solution products into the North American markets of Canada and the United States

News & Events

Expand this box to read and print

The suspension of trading in the securities of The Hydration Pharmaceuticals Company Limited will be lifted immediately following the release by HPC of an announcement regarding a placement and entitlement offer capital raising.

03/08/2023

The company releases a notice of proposed issue of securities.

03/08/2023

The company releases its Capital Raise Investor Presentation.

03/08/2023

Firm commitments to raise $1.5m at an offer price of $0.045 per share under an institutional placement. Additional 1 for 2.27 pro rata, partially underwritten, non-renounceable entitlement offer to raise up to approximately $3.3m at the Offer Price. Entitlement offer partially underwritten by BW Equities Pty Ltd for up to approximately $2.5 million. New shares will be offered with one attaching option for every two new shares issued, exercisable at $0.07 on or before 31 December 2025. In addition, PURE Asset Management to exercise approximately $0.4m worth of Warrants associated with the first tranche of its senior secured debt taking total new funding to up to ~$5.2m. Funds to be deployed towards strategic marketing and product development initiatives designed to drive revenue growth over coming quarters. Capital raise follows recent operational success and execution of strategy to reduce expenditure while maintaining consistent top-line revenue growth.

03/08/2023

The securities of The Hydration Pharmaceuticals Company Limited will be suspended from quotation immediately under Listing Rule 17.2, at the request of HPC, pending the release of an announcement regarding a capital raising.

02/08/2023

listed entity carried for record purposes only

29/12/2021

 

Click here for free access to this company's:
ASX, Legal & CGT Status

Your comments

Please read our Terms before viewing comments.

 

Company Updates

Post your comments here

Please read our Terms before posting comments.
OMISSIONS
    You can post a comment here about this company

    Please click in the "I'm not a robot" box and enter the word/figures you see in the image that then appears.

    loading Posting your comments. Please wait...

     


     

    Click here for free access to this company's:
    ASX, Legal & CGT Status

    Directors' on-market share transactions (last 5)

    rss feeds

    Purchases Sales

    DATEDIRECTORNUMBERPRICEAMOUNT
    31/05/2023George Livery50,000$0.060$3,000
    24/03/2023George Livery69,104$0.069$4,768
    07/03/2023Margaret Hardin39,130$0.069$2,700
    23/12/2022George Livery50,000$0.099$4,950
    29/06/2022George Livery50,000$0.125$6,250

    Click here for the last 20 transactions all companies

    Directors & Executives (current)

    NAMETITLEDATE OF APPT
    Adem KarafiliNon Exec Chairman15/10/2018
    Oliver BakerManaging Director, CEO13/12/2021
    Chris KavanaughCFO13/12/2021
    Margaret HardinIndependent Director08/02/2022
    Nick BerryNon Exec Director25/05/2024
    Victoria NadalinCompany Secretary

    Date of first appointment, title may have changed.

    SPECIAL NOTE: During May 2024 we are working to remove duplications in the Company Secretary role.

    Directors & Executives (former)

    NAMETITLEDATE OF APPOINTMENTDATE OF RESIGNATION
    George LiveryNon Exec Chairman, Independent Director02/11/202125/05/2024
    Gretta van RielIndependent Director02/11/202126/09/2023

    Date of first appointment, title may have changed.